Skip to content

MDMA: all studies

Page 9 of 345: studies 81 to 90 of 3,446, newest first. Back to the MDMA overview

Research

Deep venous thrombosis of the axillary and humeral veins following Ecstasy use: A case report

World Journal of Advanced Research and Reviews April 30, 2026 Khalfy Y. El, Chhaiba Y. Ould, Andaloussi Y. El

Background: 3,4-methylenedioxymethamphetamine (MDMA), or "Ecstasy," is a semi-synthetic stimulant and hallucinogen widely used recreationally. While known for producing euphoria, it is associated with severe medical complications including serotonin syndrome, rhabdomyolysis, and multi-organ failure. Although MDMA is known to cause various vascular and muscular lesions, deep venous thrombosis...

The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder

Preprints.org April 29, 2026 Stefano Marini, Domenico de Berardis preprint

Psychedelic drugs are serotonergic hallucinogens that can be divided into two types: naturally occurring (psilocybin, psilocin, and N,N-dimethyltryptamine) and synthetic (LSD, MDMA, 2,5-dimethoxy-4-iodoamphetamine, and ketamine). Psychedelics generally work on 5-hydroxytryptamine receptors and might be useful in cognitive enhancement, brain connectivity, neuroplasticity, and neuronal...

DOI: 10.20944/preprints202604.1998.v1 (opens in new tab) Addiction Autism spectrum disorder Hallucinogen Psychopathology +4

Protective effects of vitamin E and quercetin against MDMA-induced cardiac and hematological dysfunction in male wistar rats.

Pflügers Archiv: European Journal of Physiology April 23, 2026 Ayodeji Folorunsho Ajayi, David Tolulope Oluwole, Moses Agbomhere Hamed et al.

3,4-Methylenedioxymethamphetamine (MDMA), a synthetic psychoactive amphetamine derivative widely abused as the recreational drug “ecstasy,” is associated with oxidative stress–mediated cardiotoxicity and hematological disturbances. Despite documented antioxidant properties of quercetin and vitamin E individually, limited evidence exists regarding their combined protective efficacy against...

DOI: 10.1007/s00424-026-03169-w (opens in new tab) Full text (opens in new tab) Cardiotoxicity Hematology, MDMA Oxidative stress Quercetin +1

Effects of MDMA treatment and cessation on sexual behaviour and testicular functions in male sprague-dawley rats.

BMC Pharmacology and Toxicology April 11, 2026 O O Obembe, E T George, R A Mustapha et al.

BACKGROUND: 3,4-Methylenedioxymethamphetamine (MDMA) is a psychostimulant known for its social and empathogenic effects. However, its long-term impact on sexual performance and reproductive functions remain controversial. OBJECTIVE: In this study, the effects of chronic MDMA exposure and subsequent withdrawal on sexual behaviour, reproductive hormones, sperm parameters, oxidative stress,...

DOI: 10.1186/s40360-026-01131-1 (opens in new tab) Full text (opens in new tab) MDMA Inflammation Oxidative stress Reproductive hormones +1

Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use

Molecular Psychiatry April 8, 2026 Johannes G. Ramaekers, Kim P. C. Kuypers, Franz X. Vollenweider 1 citation

MDMA's history spans military experimentation, recreational use, and clinical trials for PTSD treatment, reflecting both promise and controversy. While studies in heavy users suggested possible neurotoxicity, evidence remains inconclusive. Clinical trials show that one to three sessions of MDMA-assisted psychotherapy can alleviate PTSD symptoms, yet regulators have criticized inadequate...

DOI: 10.1038/s41380-026-03602-7 (opens in new tab) Full text (opens in new tab) Neurocognitive Profiling computer programming Medline Clinical trial +2

Ecstasy (MDMA) for social anxiety in autism: a specialized application of empathogen therapy

Annals of Medicine and Surgery April 6, 2026 Mahnoor Sheikh, Zaibunnisa Bilal, Syeda Habiba Fatima et al.

To the Editor, Autism spectrum disorder (ASD) is a neurodevelopmental state in which there are early emerging problems in social communication along with fixed behavior patterns. Social difficulties in ASD are characterized by difficulty in interpretation of interpersonal signals such as facial expressions, tone of voice, and body language. Individuals with ASD often present with social...

DOI: 10.1097/ms9.0000000000004936 (opens in new tab) Ecstasy Social anxiety Social skills Social inhibition +14

The impact of antidepressant use on MDMA fatalities: A matched case-control study using a post-mortem database.

Journal of Psychopharmacology April 6, 2026 Kirsten L Rock, Paul Rees, David Morgan et al.

3,4-methylenedioxymethamphetamine (MDMA) is being investigated as a new therapy for post-traumatic stress disorder (PTSD). With antidepressants as the first-line pharmacotherapy for PTSD, it is important to understand any drug-drug interactions between antidepressants and MDMA. This study aimed to investigate the association between antidepressant use and MDMA fatality using a drug-death...

3,4-Methylenedioxymethamphetamine: From Dangerous Party Drug to Potential Therapeutic Agent

Quality in Sport April 5, 2026 Magdalena Ostaszewska, Milena Majchrzyk, Damian Zienkiewicz et al.

Introduction and aim of the study: 3,4-methylenedioxymethamphetamine (MDMA) is a stimulant drug with widespread consumption. It is used mainly in recreational settings, due to its ability to induce various pleasurable, mood-enhancing effects. Prolonged and excessive MDMA misuse can lead to multiple negative outcomes ranging from cognitive dysfunction or emotional dysregulation to severe...

Stimulants: Cocaine, Amphetamines, and MDMA

Drugs April 1, 2026 Martha S. Rosenthal

This chapter examines the pharmacology, effects, and history of stimulants, focusing on cocaine, amphetamines, MDMA, and other related substances. Cocaine plays a significant role as a medical marvel and recreational drug, available in forms such as powder and crack, which differ in potency and methods of use. Amphetamines, initially praised for their therapeutic benefits, gain attention for...

Market approval and the right to health: a human rights perspective on MDMA-assisted therapy

JME Practical Bioethics April 1, 2026 Christoph Bublitz

The application for MDMA-assisted therapy (MDMA-AT) and its rejection by the FDA in 2024 prompted a debate about ethical aspects in drug regulation. This paper examines central issues raised in that debate through the lens of human rights, especially the right to health. It argues that drug approval decisions must take into account the multipolar constellation of and dependencies between...